- Home
- CLOV vs MMI Comparison
CLOV vs MMI Comparison
Compare CLOV & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLOV | MMI |
|---|---|---|
| Founded | 2014 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CLOV | MMI |
|---|---|---|
| Price | $2.69 | $29.27 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 3 | 2 |
| Target Price | $2.90 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 5.1M | 151.1K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.78% |
| EPS Growth | 38.03 | ★ 84.38 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,924,308,000.00 | $719,700,000.00 |
| Revenue This Year | $52.59 | $14.04 |
| Revenue Next Year | $15.37 | $11.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 40.34 | N/A |
| 52 Week Low | $1.58 | $24.43 |
| 52 Week High | $3.92 | $33.62 |
Technical Indicators
Market Signals| Indicator | CLOV | MMI |
|---|---|---|
| Relative Strength Index (RSI) | 71.17 | 68.54 |
| Support Level | $2.51 | $28.27 |
| Resistance Level | $2.81 | $30.30 |
| Average True Range (ATR) | 0.13 | 0.68 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 86.79 | 96.09 |
Price Performance
Historical ComparisonAbout CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans. The Company has one reportable segment: commercial real estate services. The commercial real estate services segment is the aggregation of our two operating segments: investment sales and financing services.